Members are to be properly informed
55 The second principal matter relevant to the exercise of the Court's discretion to convene a scheme meeting is the adequacy of the information to be provided to shareholders. As noted above, s 412(1) of the Act and Sch 8 (Pt 3) of the Regulations set out the disclosure requirements of the explanatory statement (which in this case is in the form of the Scheme Booklet). If the Court is satisfied that the statutory disclosure requirements are met, it will ordinarily be satisfied that the information to be provided to shareholders is adequate for the purposes of the exercise of the Court's discretion to convene a meeting: see for example Re Opes Prime Stockbroking Ltd (2009) 179 FCR 20 at [94]-[99] and [102].
56 Each of Rex and MACH metals have adduced evidence concerning the verification, by each company, of the information contained in the Scheme Booklet. In the case of Rex, the Chief Executive Officer and Managing Director, Richard Laufmann, deposed to the steps taken by Rex to verify all information in the Scheme Booklet other than information that related specifically to MACH Metals, which steps involved senior executives of Rex and its legal advisers. In the case of MACH Metals, the company secretary of MACH Metals, Michael Howard, deposed to the steps taken by MACH Metals to verify the information in the Scheme Booklet that related specifically to MACH Metals, which steps involved senior executives of MACH Metals and its legal advisers.
57 As the Scheme is solely a members' scheme, it is necessary that the explanatory statement be registered by ASIC before the notice of meeting is sent to Rex shareholders: s 412(6) of the Act. Before registering the statement, ASIC must conclude that it appears to comply with the requirements of the Act and must form the opinion that the statement does not contain any matter that is false in a material particular or materially misleading in the form and context where it appears: s 412(8) of the Act. Rex has provided the draft Scheme Booklet to ASIC, together with all amendments.
58 Schemes of arrangement are not required to be the subject of a report by an independent expert unless the parties have a common director or the acquiring company controls 30% of the scheme company: see reg 5.1.01 and Sch 8, cl 8303 of the Regulations. Neither is applicable to the Scheme in this case. Nevertheless, Rex has obtained a report from BDO as to whether, in its opinion, the Scheme is in the best interests of Rex shareholders. BDO has expressed the opinion that, in the absence of a superior proposal, the Scheme is fair and reasonable and in the best interests of Rex shareholders.
59 One issue concerning the content of the Scheme Booklet has arisen in this matter. It concerns the recommendation to shareholders made by directors and the disclosure of directors' additional interests in the Scheme transaction.
60 Clause 8301 of Sch 8 of the Regulations relevantly requires each director of Rex to state in the explanatory statement:
(a) whether the director recommends the acceptance of the Scheme or recommends against acceptance and, in either case, his or her reasons for so recommending; or
(b) if the director is not available to consider the Scheme - that the director is not so available and the cause of his or her not being available; or
(c) in any other case - that the director does not desire to make, or does not consider himself or herself justified in making, a recommendation and, if the director so requires, his or her reasons for not wishing to do so.
61 The Scheme Booklet records the unanimous recommendation of all Rex directors that Scheme Shareholders vote to approve the Scheme. That recommendation is stated in large font on the front cover of the Scheme Booklet and in other places within the Scheme Booklet including the chairman's letter and the summary of key information.
62 Rex has five directors. Three of those directors, Mr Richard Laufmann, Ms Amber Rivamonte and Mr Andrew Seaton, will receive additional benefits if the Scheme is approved, by reason of their holding security interests in Rex that are additional to ordinary Rex shares. In those circumstances, a question that must be considered is whether it is appropriate for those directors to make a recommendation to shareholders in respect of the Scheme. A related question is whether and in what manner the recommendation should be qualified by disclosure of the director's additional interest.
63 As recognised by cl 8301(c) of Sch 8 of the Regulations, a director may consider that he or she is not justified in making a recommendation to shareholders with respect to a scheme. In some circumstances, the director may have a material personal interest in the outcome of the Scheme which is not shared with the shareholders. The material personal interest may be of such a kind and such a magnitude that it would necessarily colour the director's opinion with respect to the scheme (either positively or negatively) and make it improper for the director to purport to give a recommendation to shareholders.
64 Courts have expressed differing views on the question whether a director who is entitled to receive an additional benefit if the Scheme is approved should make a voting recommendation to members. In some cases, courts have taken the view that, as a general rule, a director who will receive a substantial benefit from the Scheme should decline to make a voting recommendation to shareholders, but that the making of such a recommendation may not preclude the court making orders convening a meeting if the benefits are adequately disclosed in the scheme booklet: see for example Re Gazal Corporation Ltd [2019] FCA 701 at [27]-[34], Re Ruralco Holdings Ltd [2019] FCA 878; 136 ACSR 628 at [26]-[28]; Re Nzuri Copper Ltd [2019] WASC 189 at [83]-[89]; Re Navitas Ltd; Ex parte Navitas Ltd (No 2) [2019] WASC 218 at [31]-[38]. In other cases, courts have taken the view that it will ordinarily be appropriate for a director who is to receive a financial benefit to make a voting recommendation, but such benefits should be fully and prominently disclosed in the Scheme Booklet: see for example, Re SMS Management & Technology Ltd [2017] VSC 257 at [24]-[26]; Re Kidman Resources Ltd [2019] FCA 1226; 139 ACSR 122 at [104]-[115]; Re QMS Media Ltd [2019] FCA 2172 at [85]-[88]; Re RXP Services Ltd [2021] FCA 38 at [41]-[48]; Re BINGO Industries Ltd [2021] NSWSC 798 at [14]-[16]; Re Villa World Ltd [2019] NSWSC 1207; 139 ACSR 550 at [27]-[40]; Re ERM Power Ltd [2019] NSWSC 1502 at [16]-[18]; Re Isentia Group Ltd [2021] NSWSC 910 at [19]; Re Japara Healthcare Limited [2021] FCA 1150; 156 ACSR 695 at [72].
65 In Re Wellcom Group Ltd [2019] FCA 1655 at [51] and [59], I expressed the view that the divergence in the authorities on this question may be more apparent than real. In each matter it will be the court's role, in accordance with its supervisory jurisdiction under s 411, to scrutinise any director voting recommendations and the circumstances in which they are made. This includes the nature of the disclosure of any additional benefits to be received by directors if the scheme is implemented. As Vaughan J observed in Re Mod Resources Ltd [2019] WASC 326 at [86], the question is fact sensitive.
66 In the present matter, each of Mr Laufmann, Ms Rivamonte and Mr Seaton will benefit from the early vesting of options held by them if the Scheme is approved. Having regard to the Scheme Consideration of $0.47 per Scheme Share, if vested the value of the options held by those directors would be $350,000 in respect of each of Mr Laufmann and Ms Rivamonte, and $13,067 in respect of Mr Seaton. In my view, those additional benefits do not preclude Mr Laufmann, Ms Rivamonte and Mr Seaton from making a recommendation to shareholders. The options held by the directors afford them an interest in Rex, and the outcome of the Scheme, of an equivalent kind to a shareholding interest, with the result that their recommendation is unlikely to be materially coloured by the interest. It is nonetheless appropriate that proper disclosure of the additional benefit is made in the Scheme Booklet.
67 Each of Mr Laufmann and Ms Rivamonte also hold consideration rights which, as discussed above, formed part of the consideration paid for the sale to Rex of the Hog Ranch mining interests in 2019. If the Scheme is approved by Rex shareholders by 31 October 2024, each consideration right will convert into one Rex share. If that does not occur, all of the consideration rights will expire (as the relevant milestones for the vesting of the consideration rights will not have been achieved). Having regard to the Scheme Consideration of $0.47 per Scheme Share, if the Scheme is approved by 31 October 2024, Mr Laufmann will effectively receive a payment $455,537 in respect of the consideration rights and Ms Rivamonte will receive a payment of $1,822,146. Those are material benefits to each of Mr Laufmann and Ms Rivamonte. They are benefits that will be lost if the Scheme is not approved by 31 October 2024. It is reasonable to assume that those additional benefits may influence the decision of Mr Laufmann and Ms Rivamonte to recommend the Scheme to shareholders. In the circumstances, a question arises whether it is appropriate for Mr Laufmann and Ms Rivamonte to make a recommendation to shareholders.
68 Having considered the nature of the Scheme and the information in the Scheme Booklet, including particularly the independent expert report, I do not consider that the Court should prevent Mr Laufmann and Ms Rivamonte from making a recommendation to shareholders. Ultimately, it is a matter for Mr Laufmann and Ms Rivamonte to determine whether they are able to do so without being unduly compromised by the additional payments they are due to receive if the Scheme is approved before 31 October 2024. In that context, the opinion of BDO as an independent expert, that in the absence of a superior proposal the Scheme is fair and reasonable and in the best interests of Rex shareholders, is a relevant factor.
69 Nevertheless, it is important that shareholders are made aware of the directors' additional interests in the Scheme transaction when reading the directors' recommendation. This is particularly the case in respect of the consideration rights held by Mr Laufmann and Ms Rivamonte.
70 In that respect, the draft Scheme Booklet provided to the Court was inadequate in two respects. First, the directors' recommendation was stated in large font on the front cover of the Scheme Booklet, but without any qualification concerning the directors' interests in the Scheme. At the request of the Court, Rex agreed to amend the front cover to include a statement, in equally large font, to the effect that, when considering the recommendation of the directors, shareholders should note that certain Rex directors will receive benefits if the Scheme proceeds and referring shareholders to relevant parts of the Scheme Booklet. Second, at other parts of the Scheme Booklet where the directors' recommendation was repeated, statements were made concerning the value of options held by the directors but not the value of the consideration rights. Again at the request of the Court, Rex agreed to amend those sections of the Scheme Booklet to make reference to the value of the consideration rights. With those amendments, I am satisfied that the Scheme Booklet provides adequate disclosure of the additional benefits the directors will receive should the Scheme proceed.